

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.63024130 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.63024130 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.45927940 |
| 4 | negative thymic T cell selection (GO:0045060) | 5.67767999 |
| 5 | negative T cell selection (GO:0043383) | 5.66987275 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.55333843 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.53545376 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.26797208 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.16870161 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.07660065 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.97790411 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.96873997 |
| 13 | thymic T cell selection (GO:0045061) | 4.95489949 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.89434460 |
| 15 | positive T cell selection (GO:0043368) | 4.82828769 |
| 16 | layer formation in cerebral cortex (GO:0021819) | 4.82491149 |
| 17 | T cell selection (GO:0045058) | 4.79623028 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.79580277 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.75618433 |
| 20 | leukocyte aggregation (GO:0070486) | 4.74901073 |
| 21 | synaptic vesicle maturation (GO:0016188) | 4.73629569 |
| 22 | positive regulation of synapse maturation (GO:0090129) | 4.46044186 |
| 23 | tolerance induction (GO:0002507) | 4.34523082 |
| 24 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.30583207 |
| 25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.29180245 |
| 26 | NIK/NF-kappaB signaling (GO:0038061) | 4.26171870 |
| 27 | response to interleukin-15 (GO:0070672) | 4.25424764 |
| 28 | synaptic vesicle exocytosis (GO:0016079) | 4.03178524 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.99908618 |
| 30 | T cell migration (GO:0072678) | 3.94841063 |
| 31 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.91703987 |
| 32 | locomotory exploration behavior (GO:0035641) | 3.80179951 |
| 33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.79305513 |
| 34 | glutamate secretion (GO:0014047) | 3.78955611 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.76953250 |
| 36 | regulation of T cell tolerance induction (GO:0002664) | 3.72841178 |
| 37 | negative regulation of microtubule polymerization (GO:0031115) | 3.69874401 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 3.69670044 |
| 39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.68250878 |
| 40 | positive regulation of granulocyte differentiation (GO:0030854) | 3.67448579 |
| 41 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.61838874 |
| 42 | cell migration in hindbrain (GO:0021535) | 3.50966557 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 3.49895532 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 3.49895532 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.49895532 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.49895532 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.49895532 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 3.49895532 |
| 49 | sodium ion export (GO:0071436) | 3.47066117 |
| 50 | regulation of B cell differentiation (GO:0045577) | 3.46941860 |
| 51 | regulation of synapse structural plasticity (GO:0051823) | 3.46910063 |
| 52 | activated T cell proliferation (GO:0050798) | 3.46663360 |
| 53 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.45719278 |
| 54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.44912632 |
| 55 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.44406535 |
| 56 | histone H3-K36 demethylation (GO:0070544) | 3.43535890 |
| 57 | detection of other organism (GO:0098543) | 3.41853983 |
| 58 | detection of bacterium (GO:0016045) | 3.40305618 |
| 59 | central nervous system myelination (GO:0022010) | 3.33091985 |
| 60 | axon ensheathment in central nervous system (GO:0032291) | 3.33091985 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 3.33077814 |
| 62 | response to muramyl dipeptide (GO:0032495) | 3.32424338 |
| 63 | activation of protein kinase A activity (GO:0034199) | 3.31604377 |
| 64 | alpha-linolenic acid metabolic process (GO:0036109) | 3.31254449 |
| 65 | negative regulation of interleukin-12 production (GO:0032695) | 3.31250799 |
| 66 | regulation of necroptotic process (GO:0060544) | 3.30281559 |
| 67 | neurotransmitter secretion (GO:0007269) | 3.29370829 |
| 68 | germinal center formation (GO:0002467) | 3.28523904 |
| 69 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.28130657 |
| 70 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.25506520 |
| 71 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.23510056 |
| 72 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.22238259 |
| 73 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.21696628 |
| 74 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18229740 |
| 75 | T cell receptor signaling pathway (GO:0050852) | 3.17857115 |
| 76 | L-phenylalanine metabolic process (GO:0006558) | 3.17389683 |
| 77 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.17389683 |
| 78 | response to pheromone (GO:0019236) | 3.17320071 |
| 79 | cell communication by electrical coupling (GO:0010644) | 3.16011845 |
| 80 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.15218987 |
| 81 | regulation of tolerance induction (GO:0002643) | 3.13762586 |
| 82 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.13455156 |
| 83 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.13455156 |
| 84 | nucleobase catabolic process (GO:0046113) | 3.13325487 |
| 85 | vocalization behavior (GO:0071625) | 3.13139953 |
| 86 | T cell homeostasis (GO:0043029) | 3.11968429 |
| 87 | cerebellar Purkinje cell layer development (GO:0021680) | 3.11152044 |
| 88 | regulation of synaptic vesicle transport (GO:1902803) | 3.11126903 |
| 89 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.10389000 |
| 90 | L-phenylalanine catabolic process (GO:0006559) | 3.10389000 |
| 91 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.08591030 |
| 92 | neuromuscular process controlling balance (GO:0050885) | 3.08410526 |
| 93 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.07760280 |
| 94 | regulation of regulatory T cell differentiation (GO:0045589) | 3.06090210 |
| 95 | interferon-gamma production (GO:0032609) | 3.05922663 |
| 96 | establishment of mitochondrion localization (GO:0051654) | 3.02466808 |
| 97 | B cell homeostasis (GO:0001782) | 3.02105911 |
| 98 | protein localization to synapse (GO:0035418) | 3.01892070 |
| 99 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00831471 |
| 100 | regulation of granulocyte differentiation (GO:0030852) | 2.99627766 |
| 101 | lung epithelium development (GO:0060428) | 2.99126084 |
| 102 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.99002323 |
| 103 | macrophage activation involved in immune response (GO:0002281) | 2.98801629 |
| 104 | regulation of defense response to virus by virus (GO:0050690) | 2.97949232 |
| 105 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.97867013 |
| 106 | regulation of synapse maturation (GO:0090128) | 2.97564568 |
| 107 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.96402462 |
| 108 | dendritic spine morphogenesis (GO:0060997) | 2.96078560 |
| 109 | lymphocyte homeostasis (GO:0002260) | 2.95018428 |
| 110 | response to laminar fluid shear stress (GO:0034616) | 2.94932504 |
| 111 | positive regulation of tolerance induction (GO:0002645) | 2.94607213 |
| 112 | dendrite morphogenesis (GO:0048813) | 2.94325573 |
| 113 | mating behavior (GO:0007617) | 2.94300684 |
| 114 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93681625 |
| 115 | cellular extravasation (GO:0045123) | 2.93670312 |
| 116 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.93056212 |
| 117 | mitochondrion transport along microtubule (GO:0047497) | 2.93056212 |
| 118 | neutrophil activation involved in immune response (GO:0002283) | 2.92905851 |
| 119 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.92096451 |
| 120 | type I interferon signaling pathway (GO:0060337) | 2.91990562 |
| 121 | cellular response to type I interferon (GO:0071357) | 2.91990562 |
| 122 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.91782133 |
| 123 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88633496 |
| 124 | negative regulation of necroptotic process (GO:0060546) | 2.88183903 |
| 125 | response to type I interferon (GO:0034340) | 2.87925798 |
| 126 | gamma-aminobutyric acid transport (GO:0015812) | 2.87494420 |
| 127 | exploration behavior (GO:0035640) | 2.87385630 |
| 128 | neuromuscular process controlling posture (GO:0050884) | 2.87001512 |
| 129 | myeloid dendritic cell differentiation (GO:0043011) | 2.86600755 |
| 130 | lysine catabolic process (GO:0006554) | 2.86407489 |
| 131 | lysine metabolic process (GO:0006553) | 2.86407489 |
| 132 | glycine transport (GO:0015816) | 2.86131746 |
| 133 | respiratory burst (GO:0045730) | 2.85311801 |
| 134 | positive regulation of interleukin-2 production (GO:0032743) | 2.85282184 |
| 135 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85076828 |
| 136 | negative regulation of phagocytosis (GO:0050765) | 2.83914845 |
| 137 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83899308 |
| 138 | neuronal action potential propagation (GO:0019227) | 2.83541424 |
| 139 | defense response to protozoan (GO:0042832) | 2.81850097 |
| 140 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.81763835 |
| 141 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.80253754 |
| 142 | negative regulation of innate immune response (GO:0045824) | 2.79136014 |
| 143 | proline transport (GO:0015824) | 2.77961950 |
| 144 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.77069400 |
| 145 | myeloid dendritic cell activation (GO:0001773) | 2.76897273 |
| 146 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.74359262 |
| 147 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.74359262 |
| 148 | organelle transport along microtubule (GO:0072384) | 2.73783575 |
| 149 | signal complex assembly (GO:0007172) | 2.73254748 |
| 150 | cellular response to interleukin-4 (GO:0071353) | 2.73253845 |
| 151 | cellular potassium ion homeostasis (GO:0030007) | 2.72998525 |
| 152 | negative regulation of type 2 immune response (GO:0002829) | 2.72280168 |
| 153 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.71171841 |
| 154 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.70210431 |
| 155 | regulation of alpha-beta T cell activation (GO:0046634) | 2.69824981 |
| 156 | alpha-beta T cell differentiation (GO:0046632) | 2.68925241 |
| 157 | natural killer cell differentiation (GO:0001779) | 2.65573355 |
| 158 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.65095479 |
| 159 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.64980652 |
| 160 | axon cargo transport (GO:0008088) | 2.64566725 |
| 161 | aspartate family amino acid catabolic process (GO:0009068) | 2.64238358 |
| 162 | macroautophagy (GO:0016236) | 2.64105935 |
| 163 | neuron recognition (GO:0008038) | 2.62920468 |
| 164 | negative regulation of cell size (GO:0045792) | 2.60629073 |
| 165 | vesicle transport along microtubule (GO:0047496) | 2.59048929 |
| 166 | dicarboxylic acid catabolic process (GO:0043649) | 2.57631796 |
| 167 | establishment of nucleus localization (GO:0040023) | 2.56965612 |
| 168 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.55700686 |
| 169 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.55165260 |
| 170 | neuron cell-cell adhesion (GO:0007158) | 2.54828716 |
| 171 | neurotransmitter transport (GO:0006836) | 2.53089359 |
| 172 | glutamate metabolic process (GO:0006536) | 2.49879800 |
| 173 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.49732431 |
| 174 | epithelial cell fate commitment (GO:0072148) | 2.49500160 |
| 175 | glyoxylate metabolic process (GO:0046487) | 2.49454606 |
| 176 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.46764362 |
| 177 | lens fiber cell development (GO:0070307) | 2.43127056 |
| 178 | axonal fasciculation (GO:0007413) | 2.43044988 |
| 179 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.42459929 |
| 180 | regulation of neurotransmitter levels (GO:0001505) | 2.41273806 |
| 181 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.38935843 |
| 182 | cellular sodium ion homeostasis (GO:0006883) | 2.38932569 |
| 183 | suckling behavior (GO:0001967) | 2.38696939 |
| 184 | cellular ketone body metabolic process (GO:0046950) | 2.38297524 |
| 185 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.37079843 |
| 186 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.37003424 |
| 187 | regulation of ARF protein signal transduction (GO:0032012) | 2.36723302 |
| 188 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.36317820 |
| 189 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.36317820 |
| 190 | alanine transport (GO:0032328) | 2.35773947 |
| 191 | membrane repolarization (GO:0086009) | 2.35389978 |
| 192 | cell communication involved in cardiac conduction (GO:0086065) | 2.32298911 |
| 193 | axon extension (GO:0048675) | 2.31566775 |
| 194 | cerebellar granule cell differentiation (GO:0021707) | 2.31024213 |
| 195 | peptidyl-arginine methylation (GO:0018216) | 2.30012966 |
| 196 | peptidyl-arginine N-methylation (GO:0035246) | 2.30012966 |
| 197 | 2-oxoglutarate metabolic process (GO:0006103) | 2.28491586 |
| 198 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.26440267 |
| 199 | innervation (GO:0060384) | 2.25689588 |
| 200 | regulation of early endosome to late endosome transport (GO:2000641) | 2.25180629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.67817958 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.38460073 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.97664441 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.56008655 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.40255345 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.17147197 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.08437934 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.96236491 |
| 9 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.86526724 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.86200555 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.79438854 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.77487692 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.70174891 |
| 14 | * MYB_26560356_Chip-Seq_TH2_Human | 2.63272214 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61455903 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60648839 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.59355624 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.58366096 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.57521333 |
| 20 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.56440361 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45927920 |
| 22 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.41891006 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.41664262 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.41169486 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.36102666 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35954890 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.33999920 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 2.31137483 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.29714875 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.29364101 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 2.27008988 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.26641970 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.23957503 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.20036193 |
| 35 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.18472057 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17597171 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.16816395 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.15951623 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.15164475 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14930331 |
| 41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14175894 |
| 42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.12983037 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.06007898 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04816956 |
| 45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.02644372 |
| 46 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.02644372 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00639886 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.98666096 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.98364105 |
| 50 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.95671587 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95355261 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94689016 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.94286122 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93774601 |
| 55 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.92491471 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89994469 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.89259014 |
| 58 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.88592515 |
| 59 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87557529 |
| 60 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.87460874 |
| 61 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.87291057 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.86120808 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84380710 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.84227586 |
| 65 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.83074660 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.82983146 |
| 67 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.81199627 |
| 68 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.80442806 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79304673 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76861736 |
| 71 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75327608 |
| 72 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.74768254 |
| 73 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73260751 |
| 74 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.72621364 |
| 75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.72065083 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69089097 |
| 77 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.65210928 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65002769 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59680853 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59319386 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.57886897 |
| 82 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.57788937 |
| 83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56405341 |
| 84 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.55623920 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.55294198 |
| 86 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.54654856 |
| 87 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51025953 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50164177 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49646637 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.48770046 |
| 91 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.47925555 |
| 92 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45811034 |
| 93 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45127268 |
| 94 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.39659464 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39215831 |
| 96 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.38981147 |
| 97 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.38706729 |
| 98 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38017686 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37631732 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37103498 |
| 101 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.36552445 |
| 102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35031003 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.34648756 |
| 104 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.33889625 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33697883 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.30979294 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29871049 |
| 108 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.29247059 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28927529 |
| 110 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.27260772 |
| 111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26796994 |
| 112 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26201694 |
| 113 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.26090070 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25027259 |
| 115 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23164437 |
| 116 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21813853 |
| 117 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.21736079 |
| 118 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.20965419 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20654934 |
| 120 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20638310 |
| 121 | P68_20966046_ChIP-Seq_HELA_Human | 1.20321791 |
| 122 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.20204157 |
| 123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17934490 |
| 124 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17094845 |
| 125 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16900334 |
| 126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14553691 |
| 127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13693980 |
| 128 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13598216 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13519050 |
| 130 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13486897 |
| 131 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13481482 |
| 132 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13291886 |
| 133 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12925629 |
| 134 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11731004 |
| 135 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11148112 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10562458 |
| 137 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09420732 |
| 138 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06616806 |
| 139 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06033933 |
| 140 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05422870 |
| 141 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.04287912 |
| 142 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.04287722 |
| 143 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04235067 |
| 144 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04068511 |
| 145 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.03863058 |
| 146 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03492126 |
| 147 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03072386 |
| 148 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00543222 |
| 149 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00326732 |
| 150 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00081511 |
| 151 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00035822 |
| 152 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98780280 |
| 153 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98185671 |
| 154 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98023444 |
| 155 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96417517 |
| 156 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95865068 |
| 157 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95778840 |
| 158 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95446818 |
| 159 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95434394 |
| 160 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95031792 |
| 161 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94765616 |
| 162 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94719743 |
| 163 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94273987 |
| 164 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94206450 |
| 165 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.93996238 |
| 166 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93890975 |
| 167 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93784713 |
| 168 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.93190724 |
| 169 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92441081 |
| 170 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91796506 |
| 171 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.91288444 |
| 172 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90796443 |
| 173 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90684153 |
| 174 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90011804 |
| 175 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89755810 |
| 176 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.88634899 |
| 177 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88533859 |
| 178 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.88285054 |
| 179 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87965941 |
| 180 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87784990 |
| 181 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86572382 |
| 182 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86120199 |
| 183 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.83871864 |
| 184 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83822538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.78446714 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.49848446 |
| 3 | MP0003436_decreased_susceptibility_to | 3.96090967 |
| 4 | MP0003880_abnormal_central_pattern | 3.78176250 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.53006556 |
| 6 | MP0004270_analgesia | 3.36688537 |
| 7 | MP0003724_increased_susceptibility_to | 3.24392249 |
| 8 | MP0003300_gastrointestinal_ulcer | 3.07988165 |
| 9 | MP0001800_abnormal_humoral_immune | 3.06843595 |
| 10 | MP0003303_peritoneal_inflammation | 3.05468980 |
| 11 | MP0001835_abnormal_antigen_presentation | 3.02926712 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.91892530 |
| 13 | MP0005671_abnormal_response_to | 2.89420170 |
| 14 | MP0003635_abnormal_synaptic_transmissio | 2.87684354 |
| 15 | MP0003329_amyloid_beta_deposits | 2.87160928 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.79837389 |
| 17 | MP0008260_abnormal_autophagy | 2.67872553 |
| 18 | MP0005451_abnormal_body_composition | 2.61745062 |
| 19 | MP0005387_immune_system_phenotype | 2.57680346 |
| 20 | MP0001790_abnormal_immune_system | 2.57680346 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.55989822 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.54399689 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 2.52867912 |
| 24 | MP0001819_abnormal_immune_cell | 2.51976025 |
| 25 | MP0002723_abnormal_immune_serum | 2.51795288 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.46425608 |
| 27 | MP0005025_abnormal_response_to | 2.40116752 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 2.39558252 |
| 29 | MP0000685_abnormal_immune_system | 2.39240463 |
| 30 | MP0002909_abnormal_adrenal_gland | 2.33743233 |
| 31 | MP0002419_abnormal_innate_immunity | 2.31625075 |
| 32 | MP0002398_abnormal_bone_marrow | 2.29948924 |
| 33 | MP0004858_abnormal_nervous_system | 2.28165584 |
| 34 | MP0002063_abnormal_learning/memory/cond | 2.22030084 |
| 35 | MP0000703_abnormal_thymus_morphology | 2.20437745 |
| 36 | MP0010155_abnormal_intestine_physiology | 2.11191207 |
| 37 | MP0000716_abnormal_immune_system | 2.09063411 |
| 38 | MP0009785_altered_susceptibility_to | 2.06111741 |
| 39 | MP0002064_seizures | 2.02763281 |
| 40 | MP0002405_respiratory_system_inflammati | 2.01230337 |
| 41 | MP0005360_urolithiasis | 1.98688968 |
| 42 | MP0004947_skin_inflammation | 1.96124407 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.92163943 |
| 44 | MP0002722_abnormal_immune_system | 1.90937339 |
| 45 | MP0001873_stomach_inflammation | 1.88850544 |
| 46 | MP0009745_abnormal_behavioral_response | 1.86541075 |
| 47 | MP0004885_abnormal_endolymph | 1.86418922 |
| 48 | MP0002734_abnormal_mechanical_nocicepti | 1.85771688 |
| 49 | MP0005365_abnormal_bile_salt | 1.85087100 |
| 50 | MP0003866_abnormal_defecation | 1.83844530 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.83292725 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.82003920 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.80718034 |
| 54 | MP0002822_catalepsy | 1.80165464 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.78743554 |
| 56 | MP0001968_abnormal_touch/_nociception | 1.77129894 |
| 57 | MP0004381_abnormal_hair_follicle | 1.76780800 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.76623393 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.76608920 |
| 60 | MP0009840_abnormal_foam_cell | 1.76428360 |
| 61 | MP0005083_abnormal_biliary_tract | 1.75495712 |
| 62 | MP0002009_preneoplasia | 1.72254835 |
| 63 | MP0000537_abnormal_urethra_morphology | 1.72221128 |
| 64 | MP0005310_abnormal_salivary_gland | 1.71918296 |
| 65 | MP0000778_abnormal_nervous_system | 1.71700612 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.70410008 |
| 67 | MP0002429_abnormal_blood_cell | 1.69254776 |
| 68 | MP0000955_abnormal_spinal_cord | 1.68091762 |
| 69 | MP0004130_abnormal_muscle_cell | 1.63928895 |
| 70 | MP0005085_abnormal_gallbladder_physiolo | 1.63543719 |
| 71 | MP0006082_CNS_inflammation | 1.62502110 |
| 72 | MP0004811_abnormal_neuron_physiology | 1.62468201 |
| 73 | MP0002572_abnormal_emotion/affect_behav | 1.59956962 |
| 74 | MP0004233_abnormal_muscle_weight | 1.59279787 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.57912598 |
| 76 | MP0000604_amyloidosis | 1.54225000 |
| 77 | MP0001845_abnormal_inflammatory_respons | 1.54121826 |
| 78 | MP0000747_muscle_weakness | 1.53659226 |
| 79 | MP0002653_abnormal_ependyma_morphology | 1.52433545 |
| 80 | MP0002733_abnormal_thermal_nociception | 1.51860883 |
| 81 | MP0003172_abnormal_lysosome_physiology | 1.51701102 |
| 82 | MP0002396_abnormal_hematopoietic_system | 1.49902433 |
| 83 | MP0005187_abnormal_penis_morphology | 1.49513575 |
| 84 | MP0002272_abnormal_nervous_system | 1.49280635 |
| 85 | MP0009046_muscle_twitch | 1.47309959 |
| 86 | MP0000013_abnormal_adipose_tissue | 1.47173053 |
| 87 | MP0009278_abnormal_bone_marrow | 1.45723017 |
| 88 | MP0002184_abnormal_innervation | 1.44504622 |
| 89 | MP0001440_abnormal_grooming_behavior | 1.44489519 |
| 90 | MP0000751_myopathy | 1.42364507 |
| 91 | MP0006276_abnormal_autonomic_nervous | 1.42335900 |
| 92 | MP0000858_altered_metastatic_potential | 1.41847847 |
| 93 | MP0003828_pulmonary_edema | 1.40100821 |
| 94 | MP0003283_abnormal_digestive_organ | 1.39696675 |
| 95 | MP0001486_abnormal_startle_reflex | 1.37418593 |
| 96 | MP0002933_joint_inflammation | 1.36067589 |
| 97 | MP0005386_behavior/neurological_phenoty | 1.32859822 |
| 98 | MP0004924_abnormal_behavior | 1.32859822 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 1.32566329 |
| 100 | MP0001853_heart_inflammation | 1.31189106 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 1.30066649 |
| 102 | MP0010329_abnormal_lipoprotein_level | 1.29418558 |
| 103 | MP0005058_abnormal_lysosome_morphology | 1.26656807 |
| 104 | MP0001851_eye_inflammation | 1.25662348 |
| 105 | MP0001970_abnormal_pain_threshold | 1.25615333 |
| 106 | MP0002166_altered_tumor_susceptibility | 1.24705873 |
| 107 | MP0008569_lethality_at_weaning | 1.23848114 |
| 108 | MP0004510_myositis | 1.21568552 |
| 109 | MP0000490_abnormal_crypts_of | 1.20497417 |
| 110 | MP0002735_abnormal_chemical_nociception | 1.18294917 |
| 111 | MP0002066_abnormal_motor_capabilities/c | 1.16951538 |
| 112 | MP0003091_abnormal_cell_migration | 1.14842067 |
| 113 | MP0002882_abnormal_neuron_morphology | 1.14786767 |
| 114 | MP0002234_abnormal_pharynx_morphology | 1.14265608 |
| 115 | MP0008469_abnormal_protein_level | 1.13253835 |
| 116 | MP0002067_abnormal_sensory_capabilities | 1.12906863 |
| 117 | MP0002736_abnormal_nociception_after | 1.12906667 |
| 118 | MP0002998_abnormal_bone_remodeling | 1.11342667 |
| 119 | MP0005332_abnormal_amino_acid | 1.10667923 |
| 120 | MP0003633_abnormal_nervous_system | 1.10331281 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 1.08636752 |
| 122 | MP0002269_muscular_atrophy | 1.08632675 |
| 123 | MP0003137_abnormal_impulse_conducting | 1.07116872 |
| 124 | MP0001299_abnormal_eye_distance/ | 1.06667271 |
| 125 | MP0010030_abnormal_orbit_morphology | 1.06390535 |
| 126 | MP0004185_abnormal_adipocyte_glucose | 1.04756512 |
| 127 | MP0003634_abnormal_glial_cell | 1.03851321 |
| 128 | MP0001348_abnormal_lacrimal_gland | 1.02514343 |
| 129 | MP0002132_abnormal_respiratory_system | 1.01499936 |
| 130 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01384863 |
| 131 | MP0002152_abnormal_brain_morphology | 1.00119033 |
| 132 | MP0000003_abnormal_adipose_tissue | 0.98573382 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.97580280 |
| 134 | MP0002006_tumorigenesis | 0.97395330 |
| 135 | MP0004036_abnormal_muscle_relaxation | 0.96282382 |
| 136 | MP0002089_abnormal_postnatal_growth/wei | 0.95034381 |
| 137 | MP0002557_abnormal_social/conspecific_i | 0.94584871 |
| 138 | MP0003879_abnormal_hair_cell | 0.92831896 |
| 139 | MP0009764_decreased_sensitivity_to | 0.91425119 |
| 140 | MP0003448_altered_tumor_morphology | 0.91035582 |
| 141 | MP0001529_abnormal_vocalization | 0.89499893 |
| 142 | MP0001663_abnormal_digestive_system | 0.88658380 |
| 143 | MP0003631_nervous_system_phenotype | 0.88445311 |
| 144 | MP0002118_abnormal_lipid_homeostasis | 0.88371608 |
| 145 | MP0003806_abnormal_nucleotide_metabolis | 0.87155139 |
| 146 | MP0004883_abnormal_blood_vessel | 0.86664925 |
| 147 | MP0002069_abnormal_eating/drinking_beha | 0.86661472 |
| 148 | MP0001501_abnormal_sleep_pattern | 0.84383541 |
| 149 | MP0004215_abnormal_myocardial_fiber | 0.82767692 |
| 150 | MP0002229_neurodegeneration | 0.80227937 |
| 151 | MP0003119_abnormal_digestive_system | 0.79566749 |
| 152 | MP0001545_abnormal_hematopoietic_system | 0.79417523 |
| 153 | MP0005397_hematopoietic_system_phenotyp | 0.79417523 |
| 154 | MP0004142_abnormal_muscle_tone | 0.79225001 |
| 155 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78938419 |
| 156 | MP0002090_abnormal_vision | 0.78430247 |
| 157 | MP0005535_abnormal_body_temperature | 0.78029592 |
| 158 | MP0008874_decreased_physiological_sensi | 0.78011528 |
| 159 | MP0002019_abnormal_tumor_incidence | 0.77598750 |
| 160 | MP0010234_abnormal_vibrissa_follicle | 0.76901480 |
| 161 | MP0003690_abnormal_glial_cell | 0.76122805 |
| 162 | MP0003656_abnormal_erythrocyte_physiolo | 0.74411405 |
| 163 | MP0004085_abnormal_heartbeat | 0.74100356 |
| 164 | MP0002254_reproductive_system_inflammat | 0.73379770 |
| 165 | MP0005621_abnormal_cell_physiology | 0.72920405 |
| 166 | MP0002078_abnormal_glucose_homeostasis | 0.72723672 |
| 167 | MP0009763_increased_sensitivity_to | 0.71302573 |
| 168 | MP0004084_abnormal_cardiac_muscle | 0.70625240 |
| 169 | MP0003861_abnormal_nervous_system | 0.70503852 |
| 170 | MP0004087_abnormal_muscle_fiber | 0.69717137 |
| 171 | MP0001666_abnormal_nutrient_absorption | 0.69563493 |
| 172 | MP0005220_abnormal_exocrine_pancreas | 0.67730375 |
| 173 | MP0003632_abnormal_nervous_system | 0.66698602 |
| 174 | MP0002332_abnormal_exercise_endurance | 0.66425790 |
| 175 | MP0005166_decreased_susceptibility_to | 0.66370345 |
| 176 | MP0000249_abnormal_blood_vessel | 0.65173826 |
| 177 | MP0005375_adipose_tissue_phenotype | 0.64704598 |
| 178 | MP0006035_abnormal_mitochondrial_morpho | 0.64327492 |
| 179 | MP0003453_abnormal_keratinocyte_physiol | 0.64293400 |
| 180 | MP0005666_abnormal_adipose_tissue | 0.64239254 |
| 181 | MP0005390_skeleton_phenotype | 0.63642354 |
| 182 | MP0008004_abnormal_stomach_pH | 0.63620781 |
| 183 | MP0002877_abnormal_melanocyte_morpholog | 0.62848001 |
| 184 | MP0003195_calcinosis | 0.62801803 |
| 185 | MP0003795_abnormal_bone_structure | 0.62178350 |
| 186 | MP0000569_abnormal_digit_pigmentation | 0.61832786 |
| 187 | MP0003279_aneurysm | 0.60119597 |
| 188 | MP0005076_abnormal_cell_differentiation | 0.58652927 |
| 189 | MP0003045_fibrosis | 0.55585742 |
| 190 | MP0009765_abnormal_xenobiotic_induced | 0.53920038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.00210298 |
| 2 | T lymphocytopenia (HP:0005403) | 4.59170541 |
| 3 | Myokymia (HP:0002411) | 4.52802580 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.12655006 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.10193417 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.08252349 |
| 7 | Stomatitis (HP:0010280) | 4.07842794 |
| 8 | Myositis (HP:0100614) | 4.04898749 |
| 9 | Abnormality of T cell number (HP:0011839) | 3.99497326 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 3.84488301 |
| 11 | Pustule (HP:0200039) | 3.81012209 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.71615130 |
| 13 | Abnormality of the lower motor neuron (HP:0002366) | 3.68567049 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.63793309 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.60705544 |
| 16 | Cerebral inclusion bodies (HP:0100314) | 3.54464140 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.53133175 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.51861295 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.50323382 |
| 20 | Orchitis (HP:0100796) | 3.49471596 |
| 21 | Visual hallucinations (HP:0002367) | 3.49320363 |
| 22 | Spontaneous hematomas (HP:0007420) | 3.46716006 |
| 23 | Meningitis (HP:0001287) | 3.46021530 |
| 24 | Recurrent viral infections (HP:0004429) | 3.39288773 |
| 25 | Cellulitis (HP:0100658) | 3.29194558 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.24426739 |
| 27 | Optic neuritis (HP:0100653) | 3.23925209 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.23925209 |
| 29 | Lymphopenia (HP:0001888) | 3.17488771 |
| 30 | Abnormality of T cells (HP:0002843) | 3.14246554 |
| 31 | Gastrointestinal inflammation (HP:0004386) | 3.13625972 |
| 32 | Megalencephaly (HP:0001355) | 3.12276666 |
| 33 | Vasculitis (HP:0002633) | 3.06336696 |
| 34 | Inflammation of the large intestine (HP:0002037) | 3.05808035 |
| 35 | Ankle clonus (HP:0011448) | 3.04128867 |
| 36 | Verrucae (HP:0200043) | 3.03079122 |
| 37 | Papilloma (HP:0012740) | 3.03079122 |
| 38 | Severe combined immunodeficiency (HP:0004430) | 3.02989545 |
| 39 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.02801988 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02154148 |
| 41 | Obstructive lung disease (HP:0006536) | 3.02154148 |
| 42 | Colitis (HP:0002583) | 3.00304774 |
| 43 | Encephalitis (HP:0002383) | 2.98758331 |
| 44 | Insidious onset (HP:0003587) | 2.98721761 |
| 45 | Termporal pattern (HP:0011008) | 2.98721761 |
| 46 | Amyotrophic lateral sclerosis (HP:0007354) | 2.94125221 |
| 47 | Focal seizures (HP:0007359) | 2.93903552 |
| 48 | Agammaglobulinemia (HP:0004432) | 2.93433054 |
| 49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.91975978 |
| 50 | Slow saccadic eye movements (HP:0000514) | 2.81384971 |
| 51 | Gastrointestinal stroma tumor (HP:0100723) | 2.78627277 |
| 52 | Urinary urgency (HP:0000012) | 2.76657158 |
| 53 | Granulocytopenia (HP:0001913) | 2.76480717 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.75921849 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.75921849 |
| 56 | Increased IgE level (HP:0003212) | 2.75637635 |
| 57 | Recurrent skin infections (HP:0001581) | 2.72962001 |
| 58 | Gingivitis (HP:0000230) | 2.72609635 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.71284200 |
| 60 | Focal motor seizures (HP:0011153) | 2.69491100 |
| 61 | Pheochromocytoma (HP:0002666) | 2.69226733 |
| 62 | Deep venous thrombosis (HP:0002625) | 2.67953100 |
| 63 | Leukocytosis (HP:0001974) | 2.64213405 |
| 64 | Chest pain (HP:0100749) | 2.62829909 |
| 65 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.55103671 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.54869344 |
| 67 | Combined immunodeficiency (HP:0005387) | 2.54070329 |
| 68 | IgG deficiency (HP:0004315) | 2.51072643 |
| 69 | Increased IgM level (HP:0003496) | 2.50105500 |
| 70 | Insomnia (HP:0100785) | 2.47692405 |
| 71 | Spastic gait (HP:0002064) | 2.47092420 |
| 72 | IgM deficiency (HP:0002850) | 2.46521881 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.45337823 |
| 74 | Depression (HP:0000716) | 2.44536876 |
| 75 | Ketosis (HP:0001946) | 2.44251646 |
| 76 | Fatigue (HP:0012378) | 2.43506869 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.43443750 |
| 78 | Impaired social interactions (HP:0000735) | 2.36446165 |
| 79 | Abnormal social behavior (HP:0012433) | 2.36446165 |
| 80 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.35740267 |
| 81 | Torticollis (HP:0000473) | 2.34620764 |
| 82 | Epistaxis (HP:0000421) | 2.33372544 |
| 83 | Gout (HP:0001997) | 2.32782657 |
| 84 | Papilledema (HP:0001085) | 2.29954751 |
| 85 | Viral hepatitis (HP:0006562) | 2.29884542 |
| 86 | Upper limb amyotrophy (HP:0009129) | 2.28726172 |
| 87 | Distal upper limb amyotrophy (HP:0007149) | 2.28726172 |
| 88 | Basal cell carcinoma (HP:0002671) | 2.26615735 |
| 89 | Eosinophilia (HP:0001880) | 2.26245312 |
| 90 | Subacute progressive viral hepatitis (HP:0006572) | 2.26021621 |
| 91 | Urticaria (HP:0001025) | 2.25880293 |
| 92 | Sepsis (HP:0100806) | 2.25013628 |
| 93 | Osteomyelitis (HP:0002754) | 2.24894010 |
| 94 | Action tremor (HP:0002345) | 2.24351042 |
| 95 | Hand muscle atrophy (HP:0009130) | 2.23741799 |
| 96 | Abnormality of eosinophils (HP:0001879) | 2.23561532 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 2.23144183 |
| 98 | Ketoacidosis (HP:0001993) | 2.22901747 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 2.21666527 |
| 100 | Mutism (HP:0002300) | 2.20081067 |
| 101 | Keratoconjunctivitis (HP:0001096) | 2.19856950 |
| 102 | Poor eye contact (HP:0000817) | 2.19346237 |
| 103 | Neuroendocrine neoplasm (HP:0100634) | 2.16642026 |
| 104 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.15642494 |
| 105 | Hemoptysis (HP:0002105) | 2.15245408 |
| 106 | Craniofacial dystonia (HP:0012179) | 2.13977866 |
| 107 | Generalized tonic-clonic seizures (HP:0002069) | 2.13890380 |
| 108 | Abnormality of T cell physiology (HP:0011840) | 2.13717474 |
| 109 | Abnormality of the corticospinal tract (HP:0002492) | 2.13023286 |
| 110 | Focal dystonia (HP:0004373) | 2.12904189 |
| 111 | Recurrent bronchitis (HP:0002837) | 2.12620752 |
| 112 | Achilles tendon contracture (HP:0001771) | 2.12589740 |
| 113 | Hypsarrhythmia (HP:0002521) | 2.11789265 |
| 114 | Chronic diarrhea (HP:0002028) | 2.11387584 |
| 115 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.10995935 |
| 116 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.10303718 |
| 117 | Difficulty running (HP:0009046) | 2.09797972 |
| 118 | Clonus (HP:0002169) | 2.09740404 |
| 119 | Xanthomatosis (HP:0000991) | 2.08187690 |
| 120 | EEG with generalized epileptiform discharges (HP:0011198) | 2.07247241 |
| 121 | Autoimmune hemolytic anemia (HP:0001890) | 2.04236575 |
| 122 | Lower limb muscle weakness (HP:0007340) | 2.03584300 |
| 123 | Lymphoma (HP:0002665) | 2.02666854 |
| 124 | Rapidly progressive (HP:0003678) | 2.01493422 |
| 125 | Hyperglycinemia (HP:0002154) | 2.00953002 |
| 126 | Teleangiectasia of the skin (HP:0100585) | 1.99573000 |
| 127 | Petechiae (HP:0000967) | 1.99029334 |
| 128 | Epileptiform EEG discharges (HP:0011182) | 1.98241099 |
| 129 | Absence seizures (HP:0002121) | 1.97603304 |
| 130 | Hematochezia (HP:0002573) | 1.97036534 |
| 131 | Restrictive lung disease (HP:0002091) | 1.96206492 |
| 132 | Neuronal loss in central nervous system (HP:0002529) | 1.96111866 |
| 133 | Postural instability (HP:0002172) | 1.95621314 |
| 134 | Limb dystonia (HP:0002451) | 1.94769330 |
| 135 | Pulmonary embolism (HP:0002204) | 1.94675114 |
| 136 | Abnormality of the fingertips (HP:0001211) | 1.93245382 |
| 137 | Acute hepatic failure (HP:0006554) | 1.93139234 |
| 138 | Turricephaly (HP:0000262) | 1.92544217 |
| 139 | Hypergammaglobulinemia (HP:0010702) | 1.92535606 |
| 140 | Cerebral hypomyelination (HP:0006808) | 1.91590499 |
| 141 | Spastic diplegia (HP:0001264) | 1.91449605 |
| 142 | Peripheral hypomyelination (HP:0007182) | 1.91347566 |
| 143 | Neonatal onset (HP:0003623) | 1.90850240 |
| 144 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89667378 |
| 145 | Abnormality of glycine metabolism (HP:0010895) | 1.89667378 |
| 146 | Status epilepticus (HP:0002133) | 1.89638593 |
| 147 | Intention tremor (HP:0002080) | 1.89620803 |
| 148 | Interstitial pulmonary disease (HP:0006530) | 1.89400796 |
| 149 | Ventricular fibrillation (HP:0001663) | 1.89306985 |
| 150 | Pointed chin (HP:0000307) | 1.89081888 |
| 151 | Dysmetria (HP:0001310) | 1.88661478 |
| 152 | Bundle branch block (HP:0011710) | 1.88626797 |
| 153 | Epileptic encephalopathy (HP:0200134) | 1.87943306 |
| 154 | Delusions (HP:0000746) | 1.87858909 |
| 155 | Abnormal eating behavior (HP:0100738) | 1.87854755 |
| 156 | Resting tremor (HP:0002322) | 1.87202142 |
| 157 | Emphysema (HP:0002097) | 1.86968669 |
| 158 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.85937255 |
| 159 | Global brain atrophy (HP:0002283) | 1.85591103 |
| 160 | Impaired pain sensation (HP:0007328) | 1.85427021 |
| 161 | Abnormality of pain sensation (HP:0010832) | 1.85427021 |
| 162 | Rigidity (HP:0002063) | 1.85020825 |
| 163 | Gingival bleeding (HP:0000225) | 1.84805116 |
| 164 | Atonic seizures (HP:0010819) | 1.84569302 |
| 165 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.84519829 |
| 166 | Glomerulopathy (HP:0100820) | 1.84259266 |
| 167 | Hemiplegia (HP:0002301) | 1.83927637 |
| 168 | Loss of speech (HP:0002371) | 1.83561269 |
| 169 | Skin ulcer (HP:0200042) | 1.81512592 |
| 170 | Dialeptic seizures (HP:0011146) | 1.80692575 |
| 171 | Hyperammonemia (HP:0001987) | 1.80018376 |
| 172 | Dysdiadochokinesis (HP:0002075) | 1.79862984 |
| 173 | Exercise-induced myalgia (HP:0003738) | 1.79178954 |
| 174 | Anxiety (HP:0000739) | 1.79064912 |
| 175 | Alacrima (HP:0000522) | 1.78346353 |
| 176 | Abnormal neuron morphology (HP:0012757) | 1.78177841 |
| 177 | Abnormality of the motor neurons (HP:0002450) | 1.78177841 |
| 178 | IgA deficiency (HP:0002720) | 1.77935814 |
| 179 | Abnormality of the peritoneum (HP:0002585) | 1.77589912 |
| 180 | Shoulder girdle muscle weakness (HP:0003547) | 1.77245874 |
| 181 | Episodic fever (HP:0001954) | 1.77053550 |
| 182 | Spastic tetraparesis (HP:0001285) | 1.77021001 |
| 183 | Hammertoe (HP:0001765) | 1.76625069 |
| 184 | Dislocated radial head (HP:0003083) | 1.75778549 |
| 185 | Spinal cord lesions (HP:0100561) | 1.75223129 |
| 186 | Syringomyelia (HP:0003396) | 1.75223129 |
| 187 | Bradykinesia (HP:0002067) | 1.74893526 |
| 188 | Muscular hypotonia of the trunk (HP:0008936) | 1.74875795 |
| 189 | Coronal craniosynostosis (HP:0004440) | 1.74653807 |
| 190 | Hyperacusis (HP:0010780) | 1.74308470 |
| 191 | Athetosis (HP:0002305) | 1.74077042 |
| 192 | Increased variability in muscle fiber diameter (HP:0003557) | 1.73977396 |
| 193 | Apathy (HP:0000741) | 1.73652120 |
| 194 | Thickened helices (HP:0000391) | 1.73400394 |
| 195 | Anorexia (HP:0002039) | 1.72747516 |
| 196 | Arterial thrombosis (HP:0004420) | 1.72588308 |
| 197 | Drooling (HP:0002307) | 1.72547087 |
| 198 | Excessive salivation (HP:0003781) | 1.72547087 |
| 199 | Hyperlipoproteinemia (HP:0010980) | 1.72466072 |
| 200 | Abnormal platelet volume (HP:0011876) | 1.70150980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.36959996 |
| 2 | MARK1 | 3.81782000 |
| 3 | MAP3K9 | 3.62957068 |
| 4 | PRPF4B | 3.54852938 |
| 5 | TRIB3 | 3.19352718 |
| 6 | KSR2 | 2.81738695 |
| 7 | RIPK4 | 2.65547570 |
| 8 | TXK | 2.60937037 |
| 9 | NTRK1 | 2.40677283 |
| 10 | NTRK3 | 2.38283881 |
| 11 | MINK1 | 2.26321080 |
| 12 | BCKDK | 2.24114219 |
| 13 | PKN2 | 2.21991307 |
| 14 | PAK6 | 2.21884717 |
| 15 | KSR1 | 2.21498792 |
| 16 | TYK2 | 2.20677049 |
| 17 | MAP2K3 | 2.14361249 |
| 18 | ZAP70 | 2.09398964 |
| 19 | MAP3K13 | 2.02016528 |
| 20 | GRK6 | 2.01586531 |
| 21 | DAPK2 | 2.00344532 |
| 22 | BLK | 1.94127639 |
| 23 | MAP3K4 | 1.93099518 |
| 24 | FES | 1.92473462 |
| 25 | CAMKK1 | 1.90179254 |
| 26 | CSK | 1.88319336 |
| 27 | JAK3 | 1.82194398 |
| 28 | IRAK4 | 1.81345456 |
| 29 | SCYL2 | 1.81194786 |
| 30 | ITK | 1.79600236 |
| 31 | EPHA4 | 1.78083232 |
| 32 | MAP3K14 | 1.78022509 |
| 33 | BTK | 1.74368679 |
| 34 | PRKD3 | 1.65267897 |
| 35 | IKBKE | 1.63693423 |
| 36 | EPHB1 | 1.55970539 |
| 37 | BUB1 | 1.53671505 |
| 38 | PHKG2 | 1.51133114 |
| 39 | PHKG1 | 1.51133114 |
| 40 | LATS2 | 1.50165512 |
| 41 | CDK19 | 1.48052360 |
| 42 | TYRO3 | 1.46016128 |
| 43 | SIK2 | 1.45332614 |
| 44 | MAP2K4 | 1.43500339 |
| 45 | RET | 1.42153988 |
| 46 | UHMK1 | 1.40680961 |
| 47 | HCK | 1.40039196 |
| 48 | MAP3K11 | 1.37030090 |
| 49 | NTRK2 | 1.36599775 |
| 50 | JAK1 | 1.35787244 |
| 51 | CDK12 | 1.34378377 |
| 52 | SYK | 1.31314774 |
| 53 | SMG1 | 1.30956110 |
| 54 | MARK3 | 1.30312447 |
| 55 | EPHB2 | 1.28869431 |
| 56 | TNK2 | 1.28628127 |
| 57 | SIK1 | 1.26695434 |
| 58 | LCK | 1.23956907 |
| 59 | NLK | 1.22799527 |
| 60 | TBK1 | 1.21943050 |
| 61 | CDK5 | 1.20319538 |
| 62 | NEK1 | 1.19365384 |
| 63 | MAP3K3 | 1.15857528 |
| 64 | MAP3K2 | 1.14997414 |
| 65 | STK10 | 1.13943046 |
| 66 | CSNK1G2 | 1.12117364 |
| 67 | ICK | 1.11576160 |
| 68 | PDGFRA | 1.11329324 |
| 69 | LIMK1 | 1.10720002 |
| 70 | DAPK1 | 1.08889004 |
| 71 | PAK3 | 1.08387058 |
| 72 | LMTK2 | 1.07546965 |
| 73 | TAOK1 | 1.05333594 |
| 74 | EEF2K | 1.01583365 |
| 75 | ARAF | 1.01448118 |
| 76 | CDK14 | 0.98270573 |
| 77 | LYN | 0.94941858 |
| 78 | TAOK2 | 0.94080219 |
| 79 | MAP3K10 | 0.94071347 |
| 80 | RIPK1 | 0.90978283 |
| 81 | FGFR3 | 0.90400164 |
| 82 | JAK2 | 0.90105774 |
| 83 | CDK18 | 0.89447298 |
| 84 | CDK15 | 0.89194038 |
| 85 | CDK4 | 0.89052615 |
| 86 | TAOK3 | 0.87660266 |
| 87 | TEC | 0.87525970 |
| 88 | STK38 | 0.85080499 |
| 89 | DYRK2 | 0.83713437 |
| 90 | ALK | 0.80128905 |
| 91 | RAF1 | 0.79685763 |
| 92 | PDK4 | 0.78860842 |
| 93 | PDK3 | 0.78860842 |
| 94 | MAPKAPK3 | 0.78496039 |
| 95 | FGFR1 | 0.78085087 |
| 96 | PRKCZ | 0.77943185 |
| 97 | FGR | 0.77803780 |
| 98 | CSF1R | 0.77533687 |
| 99 | CDC42BPA | 0.76961998 |
| 100 | CSNK1G3 | 0.76740572 |
| 101 | DYRK1B | 0.76052840 |
| 102 | CDK11A | 0.76003806 |
| 103 | MARK2 | 0.75226665 |
| 104 | TGFBR2 | 0.75034890 |
| 105 | CDK6 | 0.74216371 |
| 106 | HIPK2 | 0.73947311 |
| 107 | PASK | 0.73130651 |
| 108 | MAPK11 | 0.72922059 |
| 109 | IRAK1 | 0.71488311 |
| 110 | PIM1 | 0.70609776 |
| 111 | PRKD2 | 0.69863288 |
| 112 | FER | 0.69390202 |
| 113 | IKBKB | 0.69149136 |
| 114 | PRKCG | 0.68354038 |
| 115 | MELK | 0.67382184 |
| 116 | LRRK2 | 0.66255756 |
| 117 | BRD4 | 0.64959901 |
| 118 | STK11 | 0.64331535 |
| 119 | EPHA3 | 0.64245269 |
| 120 | IRAK3 | 0.63773386 |
| 121 | MAP2K1 | 0.63043063 |
| 122 | MAP3K7 | 0.62971861 |
| 123 | SIK3 | 0.61904749 |
| 124 | DAPK3 | 0.60412326 |
| 125 | IRAK2 | 0.60150713 |
| 126 | MAPK7 | 0.59778752 |
| 127 | PDPK1 | 0.59697004 |
| 128 | MAPK13 | 0.58557343 |
| 129 | CSNK1A1L | 0.57531216 |
| 130 | ERN1 | 0.56167468 |
| 131 | WNK3 | 0.55446288 |
| 132 | TTN | 0.54278596 |
| 133 | PTK2 | 0.54268233 |
| 134 | ROCK2 | 0.54027915 |
| 135 | ILK | 0.53644829 |
| 136 | FGFR2 | 0.51870450 |
| 137 | PDK1 | 0.48967327 |
| 138 | PRKCQ | 0.48868940 |
| 139 | FYN | 0.48407209 |
| 140 | MAP3K1 | 0.47104590 |
| 141 | MTOR | 0.47029611 |
| 142 | PTK6 | 0.46631162 |
| 143 | FGFR4 | 0.46585838 |
| 144 | PRKCH | 0.46515191 |
| 145 | CAMK4 | 0.45671271 |
| 146 | CLK1 | 0.45485273 |
| 147 | SGK494 | 0.44988731 |
| 148 | SGK223 | 0.44988731 |
| 149 | GRK5 | 0.44461438 |
| 150 | MAP3K8 | 0.44390172 |
| 151 | PNCK | 0.44236555 |
| 152 | BRSK1 | 0.43576114 |
| 153 | MAP2K7 | 0.42480687 |
| 154 | TESK2 | 0.41657146 |
| 155 | RPS6KC1 | 0.40612493 |
| 156 | RPS6KL1 | 0.40612493 |
| 157 | NEK6 | 0.40118280 |
| 158 | MAPK12 | 0.40106864 |
| 159 | CSNK1G1 | 0.39982877 |
| 160 | PINK1 | 0.39724032 |
| 161 | OXSR1 | 0.39507677 |
| 162 | ERBB2 | 0.38734741 |
| 163 | YES1 | 0.38573299 |
| 164 | RPS6KA3 | 0.38307291 |
| 165 | BCR | 0.38146231 |
| 166 | PRKAA1 | 0.38099203 |
| 167 | TESK1 | 0.38094093 |
| 168 | CAMKK2 | 0.37598373 |
| 169 | NME2 | 0.36894893 |
| 170 | KDR | 0.35760098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.94068171 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.17605925 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.61048177 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.56258855 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.48155975 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45374177 |
| 7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.32215677 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.27536461 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.22968075 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.19859138 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.09786007 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08054583 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.05886858 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.03318949 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.00577095 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.94776724 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90503548 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87437142 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.86850148 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85671063 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.84684786 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83689789 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.83180892 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.82136329 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.80690184 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76364575 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67350179 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66637672 |
| 29 | GABAergic synapse_Homo sapiens_hsa04727 | 1.65056850 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61321423 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55861775 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55011170 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.54442546 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52838488 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49355713 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.47907136 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.47538447 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.46701673 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.45086870 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44436923 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44050211 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43417435 |
| 43 | Nicotine addiction_Homo sapiens_hsa05033 | 1.40726187 |
| 44 | Long-term potentiation_Homo sapiens_hsa04720 | 1.40271521 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.39721943 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38026552 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 1.37972376 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36857758 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36642601 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36026600 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34235788 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34040672 |
| 53 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33989107 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32043786 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.31764474 |
| 56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.30872253 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.30593759 |
| 58 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.29104714 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 1.27626543 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27396829 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26667112 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 1.23919206 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23463295 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 1.21991161 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21951769 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21366265 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20624252 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20312420 |
| 69 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20173877 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.19830036 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 1.19745266 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18666984 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18399695 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16799434 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15960538 |
| 76 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.13772912 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 1.13200252 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13177479 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12847640 |
| 80 | Gap junction_Homo sapiens_hsa04540 | 1.11600348 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 1.09731906 |
| 82 | Morphine addiction_Homo sapiens_hsa05032 | 1.09619542 |
| 83 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08187916 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.07890034 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05465131 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 1.05098155 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04509324 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03408746 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03303582 |
| 90 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03001367 |
| 91 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02559079 |
| 92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02456437 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.01815130 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 1.01586892 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01027948 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.98561912 |
| 97 | Shigellosis_Homo sapiens_hsa05131 | 0.98042058 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97618174 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96376211 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.96015361 |
| 101 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95459510 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.94127946 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.93133890 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92793090 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90358382 |
| 106 | Legionellosis_Homo sapiens_hsa05134 | 0.89648685 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87953200 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87671793 |
| 109 | Axon guidance_Homo sapiens_hsa04360 | 0.87151415 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86768138 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85422668 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85330036 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.84970407 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84396584 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84077879 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83945295 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83371534 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80562960 |
| 119 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80400988 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78958423 |
| 121 | Long-term depression_Homo sapiens_hsa04730 | 0.78951492 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77868889 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73192674 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.73030981 |
| 125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70868721 |
| 126 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68666800 |
| 127 | Phagosome_Homo sapiens_hsa04145 | 0.68096371 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.67735863 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65913405 |
| 130 | Salmonella infection_Homo sapiens_hsa05132 | 0.65870859 |
| 131 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65463689 |
| 132 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64517815 |
| 133 | Melanogenesis_Homo sapiens_hsa04916 | 0.63956129 |
| 134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61884102 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61271391 |
| 136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61107233 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60525263 |
| 138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59829936 |
| 139 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59723272 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59614217 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59424844 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59393738 |
| 143 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59188367 |
| 144 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58556157 |
| 145 | Insulin resistance_Homo sapiens_hsa04931 | 0.58538036 |
| 146 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57729646 |
| 147 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56176962 |
| 148 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56001581 |
| 149 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55628832 |
| 150 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.55567521 |
| 151 | Bladder cancer_Homo sapiens_hsa05219 | 0.55088061 |
| 152 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54233320 |
| 153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54146860 |
| 154 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53958456 |
| 155 | Taste transduction_Homo sapiens_hsa04742 | 0.53872919 |
| 156 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53821340 |
| 157 | * Endocytosis_Homo sapiens_hsa04144 | 0.53387241 |
| 158 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53123446 |
| 159 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52219760 |
| 160 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49880373 |
| 161 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49847164 |
| 162 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49814776 |
| 163 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49601500 |
| 164 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49532516 |
| 165 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49089990 |
| 166 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48859044 |
| 167 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48615145 |
| 168 | Asthma_Homo sapiens_hsa05310 | 0.47927917 |
| 169 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47436597 |
| 170 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47400516 |
| 171 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46909384 |
| 172 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46739340 |
| 173 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46010107 |
| 174 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45849194 |
| 175 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45193032 |
| 176 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44829888 |
| 177 | Lysosome_Homo sapiens_hsa04142 | 0.42524756 |
| 178 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41251634 |

